Chapter 8- Political relatites of pharmacy Flashcards

1
Q

“pocketbook” issue

A

experiencing RX cost indirectly through family members or paying higher premiums

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What’s the avg. cost and time frame for bringing drugs to market?

A

10 years and over $1 billion dollars

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

How many drugs reach the market?

A

1 out of 250

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What creates a prescription for political turmoil (2)?

A
  • tremendous social value

- potentially unaffordable costs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What field is changing the basis of drug development and possibly all of health care?

A

genomics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What has our society began to grapple about as it pertains to genomics? (3)

A
  • human cloning
  • stem cell research
  • genetic privacy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Who regulates the development, testing, marketing, and manufacture of drugs?

A

FDA

The Food and Drug Administration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Who issues patents that protect new drug products from competition for a period of time?

A

PTO

The Patent and Trademark Office

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the “police”
force that stands between consumers and products that are unsafe, useless,
or improperly manufactured.

A

FDA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What directed the FDA to accelerate its review of new drug applications and
imposed fees on the companies requesting those approvals to finance the process?

A

Prescription Drug User Fee Act of 1992

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

T/F
The FDA limits financial ties between advisory committee members and companies whose products they review and DO NOT require disclosure of potential conflicts of interest.

A
  • false

- DO

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

When are herbal supplements subject to much looser standards than that of the FDA?

A

when considered a food

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Dietary Supplement Health and Education

Act (DSHEA)

A

classified herbal remedies as similar to foods and formally defined them as dietary supplements.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Under what act can herbal supplements be sold without pre-market approval?

A

DSHEA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

When can the FDA prohibit the sale of herbal products?

A

if hazards are found, only AFTER they reached the market

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

T/F?

Herbal supplement manufacturers CAN make therapeutic claims for supplements.

A
  • false

- CAN NOT

17
Q

What protects the financial interests of product innovators?

A

patents

18
Q

T/F?
Patents give inventors the right to prevent competitors from making or selling
their inventions for a period of 10 years from the date they file an application
with the PTO

A

false

20 years

19
Q

The Drug Price Competition and Patent Term Restoration Act (commonly known
as the Hatch–Waxman Act) was intended to strike a balance between what 2 goals?

A

1- to streamline and speed up the generic approval process for competing forms of existing products
2-maintain sufficient economic rewards to encourage the production of new drugs

20
Q

T/F?

FDA must wait 5 years after a patent has expired before approving a generic form?

A

true

21
Q

T/F?

Generic products CAN be marketed when the validity of its patent is in dispute?

A

false

-CAN NOT

22
Q

Manufacturing a competing biotechnology product is a matter of what?

A

duplicating a production protocol

23
Q

T/F?
There is no way to demonstrate that a new
version of a biotechnology drug is exactly the same as the original.

A

true

24
Q

bioengineered drugs are commonly referred to as what? (2)

A
  • biosimilars

- follow-on biologics

25
Q

What it the “Hatch-Waxman” for BIOSIMILAR drugs

A
  • ACA 2010

Affordable Care Act

26
Q

Affordable Care Act

(ACA)- 3

A
  • info for biosimilars is provided to generic manufacturers by original drug maker
  • shared under confidentiality protections (negotiation between parties)
  • org. manufactures receive 12 yrs. of marketing exclusivity